Clinical use of capsule endoscopy
The ability to investigate small bowel pathology, par ticularly in segments inaccessible by conventional endoscopy, has been the cardinal motive for the devel opment of WLI CE systems. Additional advantages of CE over conventional endoscopy include removing the need for patient sedation, increased patient acceptance and reduced costs [8] [9] [10] . Recommendations for the use of CE systems in the colon remain primarily confined to surveillance for patients with an incomplete assessment or contraindications to conventional endoscopy, which is more sensitive and offers interventional options 6 . Guidelines for the use of CE in clinical practice provided by the European Society of Gastroenterology (ESGE) and the American Gastroenterological Association (AGA) are summarized in Table 2 . An overview of the evidence basis for the use of CE in the diagnosis of various pathologies is provided in Supplementary Table 1 .
Small bowel
In a meta analysis comprising 396 patients with small bowel bleeding, the use of CE was associated with superior diagnostic yield compared with both enter oscopy and small bowel radiography 11 . CE is therefore
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recommended as the first line investigation modality for obscure gastrointestinal bleeding (OGIB), which is defined as gastrointestinal tract bleeding of untraceable origin on oesophagogastroduodenoscopy (EGD) and colonoscopy 6 . A limitation of current WLI CE systems is the lack of interventional capability to manage small bowel lesions. By contrast, double balloon enteroscopy (DBE), which relies on the use of a 'push and pull' tech nique assisted by the alternate inflation and deflation of two distally located overtube balloons that enables the endoscope to be advanced either in an antegrade (oral introduction) or a retrograde (anal introduction) manner, offers the opportunity to perform therapeu tic interventions such as injection of hypertonic saline adrenaline and argon plasma coagulation 6 . The use of DBE alone has a poorer diagnostic yield (diagnostic yield 56%) than CE (diagnostic yield 62%), but a complemen tary strategy of DBE following positive CE has improved detection of OGIB (diagnostic yield 75%) 12 and improved outcomes in managing OGIB (reduced recur rent bleeding and requirement for blood transfusion) 13 . Taken together, these findings suggest that performing DBE is a rational approach in patients with positive CE findings requiring biopsy or therapeutic intervention 14 . Duodenal biopsy (showing villous atrophy) with EGD complemented by raised serological markers is essential for a definitive diagnosis of coeliac disease 15 . In patients contraindicated for EGD or those declining the procedure but with positive coeliac serology and unremarkable findings on EGD, small bowel CE can be a useful diagnostic tool 16 . Small bowel CE enables assessment of complications associated with coeliac dis ease (such as intestinal T cell lymphoma and ulcerative jejunitis) and image magnification to identify patchy or distal areas of villous atrophy, which can be missed on standard upper digestive endoscopy 17, 18 . Small bowel CE has consistently shown high sensi tivity and specificity for the diagnosis of Crohn's disease. In a meta analysis including 428 patients, CE had a superior diagnostic yield compared with ileoscopy, small bowl radiography, CT enterography and magnetic res onance enterography (MRE) in patients with suspected Crohn's disease 19 . More recent studies quantified the diagnostic yield of CE in patients with suspected Crohn's disease as 76.6% compared with 44.7% for MRE 20, 21 . In addition, although MRE enables the investigation of transmural pathology, it is limited by increased exami nation time, decreased spatial resolution and increased costs compared with CE 22 . CE can have an important role in monitoring Crohn's disease activity and response to therapy, particularly with the availability of estab lished disease activity scoring systems (for example the Capsule Endoscopy Crohn's Disease Activity Index, also known as the Niv score and the Lewis score) 23 . Inadequate ampulla of Vater visualization, acting as a surrogate marker of segmental visualization of the duodenum, was identified as a limitation of axial CE 24 . Improved detection of the ampulla of Vater was reported in a separate study that evaluated the use of a lateral viewing CE platform, the CapsoCam Plus (CapsoVision, CA, USA) (diagnostic yield 70%), compared with axial viewing CE (diagnostic yield 10-44%) 25 . In a prospective study of 20 patients with familial adenomatous polyposis and Peutz-Jeghers syndrome, CE was superior to MRE in identifying polyps of <5 mm diameter 26 . CE is safe in patients who have undergone intestinal surgery and is recommended by the British Society of Gastroenterology every 1-3 years for the long term surveillance of hered itary polyposis syndromes owing to the increased risk of CRC 27, 28 .
Colon
The wide lumen of the colon means that small bowel CE devices are more likely to move in a random manner, impairing high quality image acquisition. Newer capsule endoscopes have been developed with double headed lenses, longer battery times and variable image capture rates with improved detection of colonic pathology 29, 30 . In a meta analysis of studies involving 1,292 patients that compared the performance of a second generation colon CE device (COLON2; Medtronic, Minneapolis, USA) with colonoscopy, it was found that COLON2 had a sen sitivity and specificity of 86.0% and 88.1%, respectively, for detecting polyps >6 mm and detected all invasive cancers (n = 11) identified on colonoscopy 31 . COLON2 had an equivalent performance to colonoscopy for larger polyps (>10 mm) 31 ; a confounding factor is adequacy of bowel preparation 31 . Specific regimes for optimum bowel cleansing are being developed, but they are more vigor ous than those used in conventional colonoscopy, thus potentially limiting acceptability by patients. For all the above reasons, colonic CE can be considered if colo noscopy is not complete, the procedure is contraindicated or patients are unwilling to undergo the procedure 6 .
Oesophagus
The PillCam ESO (Medtronic, Minneapolis, USA), developed in 2004, is the only WLI CE system licensed for examining the oesophagus. The capsule is equipped with a camera at both ends to improve detection of oesophageal pathology, in contrast to the single camera CE systems used for the small bowel. Oesophageal CE is increasingly considered as a potentially useful alter native investigative modality to EGD, given that EGD is more uncomfortable for the patient and more labour intensive to perform 32, 33 . However, currently, EGD
Key points
• White light imaging (WlI) remains the dominant diagnostic modality in capsule endoscopy after nearly two decades of clinical use.
• WlI technology limits diagnosis to the mucosal surface of the gut owing to the limited penetration depth of optical wavelengths beyond the tissue surface.
• In the past few years, there has been an increase in the application of non-WlI diagnostic imaging and sensing technologies to capsule endoscopy, some of which are at a more advanced stage of testing than others.
• Integrating specific diagnostic imaging technologies into capsule endoscopy devices enables submucosal imaging, improved differentiation between malignant and benign tissue and new avenues for investigating the aetiology of disease.
• many of these capsules require further testing to determine their clinical efficacy fully owing to the small sample sizes of the reported studies.
• New diagnostic capsule designs will provide new opportunities for improved computer-aided diagnosis, virtual biopsy and capsule localization that could benefit clinical practice in the future.
www.nature.com/nrgastro remains the superior diagnostic tool for the detection of oesophageal pathology (such as Barrett oesophagus or oesophageal varices) 34 .
limitations of capsule endoscopy
As shown in Table 1 , the differences between avail able WLI capsules lie mainly with the number of imaging devices, frame rate and battery life. Typically, these battery powered WLI capsules consist of one or more imagers (typically with a resolution of 320 × 240 pixels 35 ), 4-6 light emitting diodes (LEDs) to provide illumination, an onboard microprocessor and a telemetry system for transmitting images to an exter nal receiver attached to a data logger that is worn by the patient. Although the imaging resolution of CE is less than the high definition resolution possible with conventional endoscopy owing to the constraints of miniaturization, numerous studies have demonstrated good diagnostic yield of various CE devices within the small bowel for the detection of OGIB, iron deficiency anaemia and coeliac disease 36, 37 . However, the small number of comparative studies conducted so far have [38] [39] [40] [41] [42] [43] . The reliance of CE solely on WLI technology currently restricts it to the detection of mucosal mani festations of disease and prevents the evaluation of submucosal and transmural pathology 44 . Furthermore, reliance on WLI alone opens up interpretation chal lenges regarding visually obscured or occult lesions, variability in appearance, non homogeneous distribu tion and occurrence in microfoci 45, 46 . Additionally, the specificity of diagnosis based on visual changes is not reliable owing to similarities in the mucosal appearance of different small bowel diseases such as coeliac dis ease, microscopic colitis and IBD 47 . Finally, sensitivity declines when encountering low grade diseases that have not fully manifested themselves to the human eye 48 .
Taxonomy of diagnostic capsules
In the past few years, research on CE as a platform to improve diagnosis of gastrointestinal disease and to understand the underlying pathophysiology has expanded. Two research trends have been observed with regards to diagnosis. The first is the use of alter native imaging technologies, such as ultrasonography, fluorescence imaging and optical coherence tomography (OCT), and the second is the integration of non image based sensors for the measurement of physiological parameters such as pH, pressure or temperature. As seen in Table 3 , capsules with these capabilities are still in early development, with technical challenges to be overcome and further clinical testing required.
Alternative imaging
Visualizing the gastrointestinal tract using imaging alter native to WLI has the potential to enable observation of previously unseen features and to improve diagnostic sensitivity, specificity and accuracy. Attempts to over come the recognized limitations of WLI in conventional endoscopy have spurred development of alternative imaging technologies such as narrow band imaging (NBI) and chromoendoscopy 49, 50 . Both methods increase tissue contrast to improve visualization but by different means. NBI incorporates optical filters so that only blue (415 nm wavelength) and green (540 nm wavelength) light is emitted, thereby enhancing the appearance of superficial mucosal capillaries and mucosal surface pat terns and increasing haemoglobin absorption to make blood vessels appear darker. In chromoendoscopy, var ious dye solutions are sprayed onto the gastrointestinal mucosa to improve the detection of subtle mucosal dys plastic changes associated with chronic IBDs, such as ulcerative colitis. Disadvantages of the use of exogenous markers include potentially unequal distribution, pooling that can obscure lesions and lengthening of the duration 51 . These imaging modalities have also been integrated into CE [52] [53] [54] [55] , but studies have cast doubt on their efficacy compared with standard WLI cap sules [56] [57] [58] [59] . Other alternative imaging technologies such as μUS, fluorescent imaging and OCT address some of the limitations associated with WLI technology. Examples of some of these imaging modalities are shown in fig. 1 .
Ultrasonographic imaging.
Following the acceptability of endoscopic ultrasonography (EUS) in routine clini cal use, the inclusion of ultrasonography into a capsule was a desirable step to improve CE diagnostic capabili ties beyond optical imaging. The development of ultra sonographic capsule endoscopy (USCE) is currently in its infancy, and USCE was being developed by a number of teams, including the Khuri Yakub 60 63 project, which was unable to miniaturize the system to fit within the dimen sions of a swallowable capsule before the end of the pro ject, and work by Lee et al. 64 , which was not able to identify a suitable means for achieving long term rotation of the ultrasound transducer, although they produced a capsule with the required dimensions that was successfully tested in vivo. The common aim of these projects was to develop a capsule capable of transmural gastrointestinal imaging to detect submucosal (intramural) pathology.
At the heart of USCE is the development and inte gration of a suitable ultrasound transducer. 61 . Transducer frequency makes an impor tant contribution to USCE function through its strong effect on image resolution (two point discrimination) and depth of penetration. Conventional EUS typically employs ultrasound frequencies in the range 5-18 MHz, corresponding to axial resolutions of ~0.2-0.8 mm and depths of ~2-8 cm 67 . Lower frequencies (5-20 MHz) can enable imaging of organs located beyond the wall of the gastrointestinal tract, whereas higher frequencies (>25 MHz) can provide more detailed images of the gut wall. Higher frequencies are employed when staging local tumour burden using a tumour-node-metastasis (TNM) classification system, as they enable reliable means of determining tumour size and invasive extent (T stage) as well as proximal lymph node spread (N stage) [68] [69] [70] . μUS miniprobes introduced via the biopsy channel of conventional endoscopes for CRC staging have improved axial and lateral image resolution with higher than con ventional EUS frequencies 68, 71, 72 . These higher frequen cies result in highly detailed subsurface information that includes structural and cellular tissue composi tion. Additionally, there is a simultaneous decrease in the depth of tissue penetration as the frequency is increased, which has the potential to mitigate confound ing information (for example, adjacent bowel loops ver sus oedema) caused by deep penetrating soundwaves at standard frequencies in the 5-20 MHz range 73 . The Qiu and Cochran groups investigated the potential benefit of high frequency (>25 MHz) ultrasonography for high resolution, known as μUS, in their respective capsules. Cochran has demonstrated the potential of a capsule with multiple single element ultrasonic trans ducers operating at 30 MHz in imaging the layers con stituting the small bowel 4 . Although USCE is in its early [60] [61] [62] [63] [64] NBI, narrow band imaging.
Single-element transducers
Devices generally consisting of a piezoelectric material housed in a casing that can both transmit and receive ultrasound signals.
stages, the principle of submucosal bowel wall imaging is attractive, as USCE will enable deeper tissue analysis with the potential of detecting transmural inflammation and thus has the capability to assess disease activity in Crohn's disease.
Autofluorescence imaging. Autofluorescence imaging (AFI) uses short wavelengths of light, typically 380-500 nm, to illuminate tissue, exciting either endogenous or exogenous fluorophores to differentiate healthy and malignant tissue. The incident light absorbed by the tis sue causes the fluorophores to emit light at longer wave lengths, typically 490-590 nm. One study has shown that autofluorescence is reduced by a factor of 3-12 in malignant tissue compared with healthy tissue 74 . Various studies have compared the efficacy of conventional AFI endoscopy with that of conventional WLI endoscopy for the detection of gastrointestinal disease. Several of these studies have shown that AFI increases the detec tion rate of diseases such as colorectal adenoma 75 and polyps 76 compared with WLI [75] [76] [77] . The efficacy of AFI in diagnosing IBDs such as ulcerative colitis has also been examined. Studies have shown a correlation between the intensity of AFI images and the severity of the inflam mation 78, 79 , with intensity shown to be a useful marker of active inflammation in ulcerative colitis 80 . Because of this potential, there is considerable research interest in the use of AFI with conventional endoscopy, so it was logical that the integration of AFI with CE would be explored to improve the diagnostic capabilities of CE. The integration of AFI CE has led to the development of several prototype imaging devices such as those being created by the Cummings group 81 and has also contributed use of fluorescence as a sensing modality, as evidenced by the work of Demosthenous et al. 82 and Nemiroski et al. 83 .
Single photon avalanche diode (SPAD) imaging arrays, capable of detecting a single photon of light, have been successfully used in AFI CE to improve the detection of endogenous fluorophores at low light intensity, removing the risk of phototoxic reactions and photobleaching of the fluorophores 84 . Furthermore, the use of complementary metal-oxide-semiconductor (CMOS) technology in the fabrication of both the SPAD imager and the associated electronic systems is vital to reduce the power required, enabling the capsule to be powered by silver oxide batteries for up to 15 hours, a lifetime similar to those of some clinical CE devices.
SPAD imagers have been used in wireless CE proto types developed by Al Rawhani et al. 81 . The highly sen sitive SPAD pixels generate a pulse in response to each impinging photon, which enables individual photons resulting from autofluorescence to be counted. The lat est version of the capsule contains a 32 × 32 pixel SPAD imager sufficient to demonstrate the diagnostic potential of this technology 81 . However, an increase in resolution is required for routine clinical practice. Illumination in the prototype developed by Al Rawhani et al. is provided by an inexpensive, compact LED at 468 nm, with an emitted power of 78 μW being sufficient for this imager. Sensitivity is further improved by filtering out light other than that owing to fluorescence emission.
A common drawback of AFI techniques is that the signal from cancerous cells can be obscured by the auto fluorescence of healthy cells. The capsule developed by Al Rawhani et al. has yet to undergo in vivo trials, but benchmark tests have been conducted to assess its capa bility to detect autofluorescence from FAD, an endoge nous fluorophore associated with tumour growth, and the effect of haemoglobin on autofluorescence with a fluorescence emission peak of 520 nm. The minimum amount of FAD detectable with this system is 12.5 μM,
Photobleaching
The permanent loss of fluorescence in a fluorophore owing to photon-induced chemical damage. www.nature.com/nrgastro rising to 20 μM in a gut mimicking imaging phantom. Similarly, this capsule can easily detect 20 μM of fluores cein isothiocyanate (FITC). The system can also detect a reduction in autofluorescence upon the introduction of haemoglobin 81 . Capsules capable of sensing autofluorescence or fluorescence, as opposed to imaging capsules such as the Al Rawhani capsule, were created for gastro intestinal diagnosis by Demosthenous et al. 82 and Nemiroski et al. 83 . These devices detect light with photo diodes rather than SPAD imagers. Demosthenous et al. 82 used their CE device to measure the changing level of fluorescent light generated by low concentrations of an exogenous infrared fluorescent marker (indocyanine green (ICG)) to screen for cancer in ex vivo porcine small intestine. ICG was chosen as the fluorophore, as it is used to tag cancerous cells with a fluorescent signal in other regions of the gastrointestinal tract 85, 86 , and the absorption spectrum can be modified through changes in concentration. This latter property enables the excita tion wavelength to be altered for optimal detection of specific pathologies or improved tissue penetration; for instance, at low concentrations, such as those expected in small cancers, the optimum excitation wavelength is 780 nm. Increasing the concentration causes a second absorption wavelength to appear at 708 nm (refs 82,87 ).
Demosthenous and colleagues designed their autono mous system for use with 780 nm wavelength excitation, as the deeper tissue penetration depth at this wavelength is more suitable for detecting small cancers 88, 89 and the rate of false positives arising from endogenous fluoro phores within surrounding tissue that emit light in the ultraviolet and other parts of the visible spectrum is reduced 90 . The functionality of this capsule has yet to be determined in an in vivo environment. However, ex vivo experiments using porcine intestinal tissue have demonstrated the capability to detect nanomolar to micromolar concentrations of ICG, which are com parable to those that would be expected from tagged small cancers 82 . Nemiroski and colleagues designed their wireless capsule to detect gastrointestinal bleeding (GIB) 83 . Although WLI CE can be used to identify blood in the stomach, it cannot easily differentiate between past and active GIB in the stomach. Such differentiation is achieved in the Nemiroski capsule through the intra venous injection of fluorescein, a fluorescent contrast agent. Fluorescein is chosen as a proxy for active GIB, as it is FDA compliant, has a quantum yield of ~90% and the optical spectrum (absorption peak at 494 nm; emission peak at 512 nm) does not overlap with the autofluorescent spectrum of gastric juices (absorption peak at 288 nm; emission peak at 350 nm). The distance between the two pairs of emission and absorption peaks enables fluorescein to act as a biomarker for the detec tion of blood in the stomach. The capsule uses a minia turized fluorometer consisting of an LED, optics and a photodiode for detection of the emitted fluorescent signal. The LED peak wavelength is 465 nm, and the use of filters limits the light from sources other than the fluorescein that is detected by the photodiode. Benchtop tests have demonstrated that the system can detect concentrations of fluorescein as low as 20 nM. However, the performance of the system varies with the pH of the stomach, as the spectral properties and quantum yield of fluorescein shift with pH, which can be problematic after the patient ingests water. In vivo trials have yet to be carried out with this capsule.
Optical coherence tomography. OCT is a volumetric imaging technology capable of micrometre scale resolution that operates by scanning an optical beam across the sample and measuring the time delay and intensity of back scattered or back reflected light 91 . Improvements in the speed and sensitivity of OCT technology 91 , coupled with an image resolution comparable to that achieved with conventional histological analysis of excised biopsy samples (10 µm axial and 30 µm lateral resolution), make this an attractive technology for real time, in vivo virtual biopsy applications. OCT was successfully applied to in vivo studies of the duodenum in 2005 (refs 92,93 ).
An image was reconstructed from the measured light that demonstrated that the intestinal villi could be observed 93 . Studies in 2007 showed that OCT combined with EGD could be successfully used to detect coeliac disease by analysis of the villous morphology from the OCT images, with a sensitivity of 82% and specificity of 100% achieved in a study of 132 paediatric patients 94 . The potential for OCT in the diagnosis of IBD has been demonstrated by several studies, with the first reporting that transmural inflammation detected by OCT could distinguish Crohn's disease from ulcerative colitis with a sensitivity of 90.0% and specificity of 83.3% 95 . A subse quent study also found similar discrimination between ulcerative colitis and Crohn's disease 96 . Both of these studies involved 2D images, although a subsequent study generated 3D reconstructions of the colon, rectum and anal verge in patients with ulcerative colitis that visual ized the presence of large subsurface voids, ulcerations and the absence of a regular crypt pattern 97 . Attempts to integrate OCT into CE have so far been limited to two, independently produced, tethered capsule endoscopes for diagnosing oesophageal pathol ogy 98, 99 . In both referenced cases, the tether encases an optical fibre used to transmit light from an external light source to internal optics that are mechanically scanned to produce the image. The tethered capsule developed by Gora et al. 98 was 12.8 mm in diameter and 24.8 mm long with side viewing OCT capable of generating radial images at 20 frames per second with 30 μm lat eral and 7 μm axial resolution in humans. This capsule rotated the embedded OCT device using a drive shaft located within the tether sheath. The tethered cap sule could be safely used on non sedated patients, and it could be easily passed down the oesophagus owing to normal swallowing induced peristaltic force and pulled back manually. However, although manual pullback is convenient and simple compared with motorized con trol, it does not provide the stability or repeatability required for high resolution volumetric OCT, such as en face OCT, also known as C scan OCT, which pro duces transverse images beyond the mucosal surface, especially at the low frame rates achievable with the actuation mechanism used.
Quantum yield
The number of times a specific event occurs per photon absorbed by the system in a radiation-induced process.
Volumetric imaging a sequence of 2D images that are grouped together to form a 3D image of a volume of space.
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Volumetric OCT was achieved with the tethered cap sule developed by Liang et al. 99 during in vivo studies on porcine models. The capsule was 12 mm in diameter with a length of ~35 mm. This capsule utilized an OCT device that circumferentially scanned the light from an external source by a microlens that was rotated by an onboard direct current micromotor. Longitudinal scanning could be performed by either the manual force applied to the entire capsule via the tether for large field coverage or distal pneumatic actuation of an inter nal carriage within a stationary capsule for small field coverage with high stability. An advantage of using an integrated longitudinal scanning stage is the ability to track non uniformities along the scan trajectory, which facilitates compensation in post processing. The use of a semi rigid tether removed the need for peristaltic propulsion, as it made manual positioning easier than with the soft tether used by Gora et al. 98 However, the authors found that the semi rigid tether made it diffi cult to achieve smooth longitudinal scanning owing to difficulty in moving the tether at a constant speed of less than a few millimetres per second. Despite these limitations, the tethered OCT capsule achieved an axial resolution of 8.5 µm in tissue and scanning frequencies of 250 Hz and was able to produce volumetric scans with 1,750 frames over an area of 1.3 mm 2 and a depth of 3.5 mm in 7 seconds.
Currently, OCT has not been utilized in a wireless capsule format owing to several remaining technical chal lenges. One issue is the need to replace the external light source with a battery powered light source within the capsule. Another is the need for short image acquisition times for real time en face imaging so that scans can be produced within a capsule subject to peristaltic motion.
Ionizing radiation.
Ionizing radiation is a high frequency electromagnetic wave or particle, such as X rays, of sufficient energy to remove an orbital electron from an atom. X rays and other ionizing radiation can damage or destroy living tissue, so care must be taken to avoid unnecessary or excessive exposure. Alternatively, ionizing radiation can pass through the tissue of the human body, and the interaction between this radiation and the tissue can be recorded to generate images of the internal structure of the body.
Although the development of capsule endoscopy is seen by many as a means of imaging the gastrointestinal tract without the use of ionizing radiation 100 , the limita tion of current, commercially available CE to mucosal imaging has spurred development of a range of capsules capable of submucosal imaging, such as OCT and μUS. The ionizing radiation imaging C scan system from Check Cap is the closest to market and has recently gained approval from the FDA for a pilot study 101 . The C scan system (Check Cap, Isfiya, Israel) is an autono mous X raybased CE system that includes an external data logger and workstation. The novel aspect of this sys tem is the use of a weak X ray source to image the colon transmurally; furthermore, because of the nature of this imaging modality, bowel preparation consists solely of ingestion of an iodine based contrast agent taken with normal meals during capsule passage 102, 103 . The C scan CE device is 11.4 mm in diameter and 34 mm in length. The X ray source is a short lived radio isotope, 191 Os, with a half life of 15.4 days, which was chosen to balance the need for a complete examination with environmental concerns regarding device disposal after use. The emitted 65-75 keV X rays are divided into three rotating beams, enabling a 360° view of the colon wall. Image formation depends on two types of energy returned to the capsule. The first step occurs when emit ted photons interact with the ingested iodine contrast agent, producing X ray fluorescence at a low energy of 27 keV. The second step occurs with Compton scattering of the photons at 52-60 keV. By measuring these two events separately, distances from the capsule to colon can be calculated and wall abnormalities can be detected. The capsule is also equipped with an accelerometer and a magnetometer to enable capsule or pathology localiza tion for follow up. Acquired data are transmitted wire lessly to external receivers located on the patient, and the system is completed by a workstation that enables a number of 2D and 3D image reconstructions 103, 104 . A pilot study consisting of 46 individuals between 45 and 68 years of age of unknown gastrointestinal status who were assumed to be healthy assessed the functioning C scan device 102 . A parallel study performed on volun teers, aged 41-70 with no known gastrointestinal pathol ogy, that involved the swallowing of a non functioning capsule was used to assess device safety 102 . Preparation for examination involved daily ingestion of up to 50-70 ml iodine solution with food until the capsule had transited. One patient experienced a retained capsule in the caecum that was retrieved via conventional colonoscopy during the scheduled follow up. No other adverse events were reported. The average radiation dose per patient was cal culated to be 0.03 ± 0.0007 mSv; for comparison, a typical effective dose for a posterior to anterior chest radiography scan is 0.02 mSv (ref.
105
), and the dose for a similar 3D CT colonography image is ~8.8 mSv, with the specific dose dependent upon the performing institute 106 . The detec tion of pedunculated and sessile polyps, as confirmed by subsequent standard colonoscopy, was reported. Despite the lack of quantitative human data, in vivo pig trial results indicated that the device had sufficient resolution to detect 5 mm diameter implanted silicone beads 102 . As stated by the authors, further validation and direct comparison of the system with standard colonoscopy are required 102 .
Biophysical measurements
Changes in gastrointestinal activity, such as transit time, can indicate a pathological condition. To detect these situ ations, several groups have adapted CE to measure changes in physical parameters of the gastrointestinal tract, such as pressure and myoelectric activity. Ingestible capsules to measure other physical parameters, such as temperature, have also been developed for sports medicine rather than gastroenterology and are described here.
Temperature. CorTemp by HQ (Palmetto, FL, USA) is an FDA approved, wireless capsule that measures internal body temperature with an accuracy of ± 0.1 °C. Applications for monitoring internal body temperature are found in several areas, such as sports physiology,
Compton scattering
The scattering of a photon by a charge particle that results in a decrease in energy of the photon.
www.nature.com/nrgastro firefighting, research and medicine, occupational safety and military 107, 108 . These devices have not been used for the diagnosis of gastrointestinal disease owing to the nonspecific nature of temperature changes as a bio marker. One capsule that has been used in the diagnosis of gastrointestinal disease is the SmartPill (Medtronic, Yokneam, Israel), which incorporates a temperature sensor along with an integrated pH and pressure sensor. This temperature sensor is used in conjunction with the other sensors to aid the measurement of transit time through the various regions of the gastrointestinal tract. The temperature sensor has a range of 20-40 °C with an accuracy of ± 1 °C and is measured at a frequency of 0.05 Hz. This capsule is discussed in greater detail in the section describing pH sensing capsules.
Manometry. Consumed food is moved along the gastro intestinal tract via the periodic peristaltic contraction of muscles in the oesophagus, stomach and small and large intestines. During and after consumption, highly irreg ular contractions mix the food and digestive enzymes in the small intestine while slowly moving them towards the large intestine. These contractions are defined as the motility of the gastrointestinal tract. An estimated 40% of gastrointestinal conditions worldwide are associated with abnormal gastrointestinal motility (dysmotility), resulting in abdominal discomfort, pain and other intes tinal problems for 20% of the general population 109, 110 . For example, small intestine dysmotility might be symp tomatic of IBS, gastroparesis and chronic idiopathic constipation 111 . However, why and how dysmotility occurs are not fully understood.
Current methods of diagnosing dysmotility include serosally attached electrodes, barium X ray imaging, scintigraphic imaging and electrogastrography 112 . Endoscopic manometry is a commonly used proce dure; this technique involves transnasal insertion of a modified catheter containing a series of pressure sensors into the small intestine. The pressure sensors record the contractile behaviour of the gastrointestinal tract for subsequent clinical assessment 113 . As with many endo scopic procedures, manometry can be uncomfortable for patients, and most of the small intestine cannot easily be reached. Other methods that use balloons to measure the motion of the bowel wall, electropotential record ings associated with peristaltic activity or abdominal acoustic emissions have been found to be imprecise compared with endoscopic manometry 114 . A minimally invasive, reliable and versatile diagnostic tool is there fore an attractive development target for the detection and accurate characterization of gastrointestinal tract dysmotility.
Ingestible motility capsules (IMCs) offer an attrac tive alternative to other test modalities, as they provide real time in situ information about the environment of the gastrointestinal tract, such as pressure, temper ature, pH, transit time and potentially capsule location, without the need for ionizing radiation or discomfort to the patient. The acquisition of the gastrointestinal pressure profile via an IMC could replace conventional antroduodenal and colonic studies that use invasive and less well tolerated manometric catheters to quantify the contractile pressure patterns. Assessment of the pressure profile captured by a motility capsule has the potential to provide richer motility information beyond that currently recorded 115 . The SmartPill is the only FDA approved, wireless CE device with pressure sensing capabilities currently on the market 116 . The SmartPill contains a temperature sensor (25-49 °C), a pH sensor (pH 0.05-9.0), a sin gle pressure sensor with an operating range 0-46 kPa and a sensitivity of ± 0.650 kPa that can record the pres sure of its environment and an internal antenna that can transmit captured data wirelessly in real time at 433 MHz. The capsule is enclosed in a non digestible polyurethane shell, battery powered and intended for single use. The SmartPill can be used to measure gastric emptying time and small bowel, colon and whole gut transit times by evaluating combined pressure, pH and temperature profiles.
Although studies have utilized the SmartPill to dia gnose gastroparesis 117 and chronic idiopathic consti pation 118 , the presence of a single pressure sensor does not provide sufficient manometric information, as it records only the intraluminal pressure in the gastro intestinal tract and is unable to provide information on peristaltic behaviour 116, 117, [119] [120] [121] , unlike conventional manometry 121 . The recommendation by the American and European Neurogastroenterology and Motility societies for the use of the SmartPill to evaluate regional and whole gut transit time in individuals with alter ations to gastrointestinal motility in single or multiple regions 122 can be predominantly attributed to the multimodal approach of using pH, pressure and temperature sen sor data together. Recording both contractile and intra luminal pressure requires an array of pressure sensors arranged longitudinally and radially around the capsule that are sensitive to pressure changes of <0.133 kPa and can operate between 0 and 25 kPa to capture the weak peristaltic or segmentation contraction of the gastrointestinal tract 119 . Additionally, although not reported for the SmartPill, other prototype pressure sensing capsules of a similar design are susceptible to interference from respiration and heartbeats, which dominates gastrointestinal mano metric signals and requires further filtering 123, 124 . Despite these limitations, improved patient acceptance of IMCs in comparison with conventional manometry 116 and the non invasive potential of the IMC to capture multi regional gastrointestinal dysmotility are advantageous in comparison with other methods. However, further work is required before these devices can provide information comparable to conventional manometry.
Electrophysiology.
Gastrointestinal motility involves complex behaviour governed by hormonal, myogenic and neurogenic factors that act together to mix and pro pel material along the gastrointestinal tract. In the small intestine, slow waves generated by the interstitial cells of Cajal (ICCs) cause smooth muscle cells lining the intes tine to polarize and depolarize, leading to contraction and relaxation, respectively. Determining the pathophys iological role of these cells in dysmotility has attracted substantial research interest 125 . Several methods have been used to investigate the electrophysiology of the gastrointestinal tract in clinical settings. One approach is the non invasive transcutaneous measurement of the myoelectric activity of the small bowel via electro gastroenterography (EEnG). However, transcutaneous EEnG suffers from several problems, such as interfer ence between EEnG and cardiorespiratory signals and low EEnG signal amplitude 126 . The relationship between clinical presentation and EEnG data is weak, which hinders clinical acceptance 126 . One method to improve this involves the integration of EEnG within a wireless, ingestible capsule.
Woo et al. 127 reported the design, construction and testing of a wireless CE capable of measuring the slow waves generated by ICCs. This 11 mm diameter, 21 mm long capsule contained two surgical steel electrodes that contacted with the surrounding mucosa and detected the changing electrical potentials of the intestinal smooth muscles, before subsequent amplification and filtering. The system could operate for up to 18 hours with two coin sized batteries similar to those used in conventional capsule endoscopes. The capsule was tested ex vivo using two, freshly excised, samples of porcine intestine immersed in a modified Krebs solution. The results demonstrated successful detection of myoelectric activity within these tissue samples, but only at a fixed point owing to frictional forces. The size and pitch of the two electrodes limited the radial resolution of any electrophysiological mapping of the small intestine. No further results from this research have been pub lished since 2010, although the authors have adapted some of this technology as a means of electrically propelling a CE through the gastrointestinal tract 128 .
Biochemical measurements
Gastrointestinal disease can be associated with a change in the biochemical profile of luminal contents; for exam ple, levels of faecal calprotectin are elevated in patients with IBD. CE offers a unique opportunity to perform minimally invasive screening in situ, which could enable monitoring of gastrointestinal disease progression when coupled with improved capsule localization methods. Capsules capable of measuring pH, haemoglobin and changes in microbiome metabolic by products have been developed in several studies, with varying degrees of success.
pH. The pH of the healthy gastrointestinal tract varies with location, time since ingestion, age and diet 129, 130 . Changes in pH are often used in the diagnosis of GERD 131 and the measurement of gastrointestinal tran sit time through the use of CEs with suitable sensors. However, other studies have sought to demonstrate the potential of changes in pH as a marker of other gastrointestinal diseases with mixed results [132] [133] [134] [135] . Early studies used a battery powered, wireless ingest ible pH telemetry capsule with an onboard transducer comprising two reference electrodes, the output of which was sent to an external data logger via an integrated radio frequency transmitter 136 . Although these capsules were reported to experience up to 75% signal loss caused by poor alignment between the transmitting and the receiving antennas, they were considered an improvement over other methods previously used in vivo. Some stud ies have demonstrated that ulcerative colitis can cause a decrease in pH within the right colon 132, 133 , whereas results for other IBDs such as Crohn's disease have been contradictory 134, 135 . Fallingborg et al. found that three of six patients with ulcerative colitis had a proximal colon pH of 2.3-3.4 (ref.
132
). The other three patients had nor mal luminal pH profiles of 6.8-7.4 in the proximal colon. In two other studies, Nugent et al. measured a reduc tion in colonic luminal pH to <5.5 in two of six patients with ulcerative colitis when compared with healthy controls 133 , and Press et al. observed a slight increase in the higher right colonic luminal pH in 11 patients with ulcerative colitis compared with healthy control individ uals 134 . Owing to the limited sample sizes, further work is needed to verify these studies and demonstrate whether pH can act as a realistic and specific biomarker for IBD or IBD severity.
Since the development of these initial capsules, three other devices capable of detecting changes in luminal pH have become available commercially. The wire less BRAVO capsule (Medtronic, Yokneam, Israel) is a 26 mm x 6.3 mm device that is designed primarily to detect GERD by sensing and recording oesophageal pH for up to 96 hours 137 . The wireless Intellicap capsule (Philips, Eindhoven, Netherlands) is an 11 mm diameter, 27 mm long capsule for targeted drug delivery that uses its pH sensor to determine when to empty the contents of its drug reservoir into a specific region in the gastro intestinal tract. Initial tests conducted on ten human volunteers with the Intellicap showed that using the pH profile for capsule localization agreed with the posi tion determined with scintigraphy in all volunteers 138 . This capsule has been assessed primarily for therapeutic delivery [139] [140] [141] . The SmartPill is approved 116 to investigate gastro intestinal motility via integrated pH, pressure and temperature sensors that are previously described. The temperature sensing and pressure sensing capabil ities of this device have been previously discussed. The battery life of the capsule is specified to be up to 5 days, enabling data transmission throughout the entire gas trointestinal tract until excretion. Such a long battery life is achieved partly by adjusting the sampling rates of the sensors after 24 hours 142 . Protocols for measuring the transit time of the capsule from the rate of change in pH along the gastrointestinal tract have been defined 143 . Although gastrointestinal motility studies using CE to date have involved small sample sizes of <100 par ticipants and had difficulties in experimental design (particularly with respect to the selection of parti cipants 144 ), it has been suggested that the detection of gastric emptying time with CE devices such as the SmartPill in patients with suspected gastroparesis has a sensitivity and a specificity similar to those of gastric scintigraphy 145 , which is commonly used to measure transit time across the length of the gastrointestinal tract. A systematic review that compared the diagnostic capability of CE devices with gastric scintigraphy, antro duodenal manometry and endoscopy in the diagnostic accuracy of gastric emptying delay, motility assessment Although CE has primarily used pH to assess motility, there have been some studies investigating changes in pH as a means to detect disease using CE. In one study of 16 patients with IBS defined by Rome III criteria and 16 age matched control individuals, no differences in the transit times, gastrointestinal motil ity and ileal pH were found between the two groups using the SmartPill 146 . However, caecal pH was lower in patients than in the control individuals (5.12 ± 0.05 ver sus 6.16 ± 0.15; P < 0.0001), which in turn meant that the change in the ileo-caecal pH was also greater in patients than in controls (-33.8% ± 0.84 versus -18.7% ± 1.5; P < 0.0001). A moderate correlation between caecal pH and right colonic contractibility was also observed (r = 0.54; P = 0.002). The authors observed a correlation between measured values of caecal pH and contractile behaviour and theorized that the more acidic environ ment detected in patients with IBS is attributable to excessive fermentation in the caecum and associated production of short chain fatty acids. This excessive fermentation is thought to be the cause of the reduced proximal colonic motor activity that was detected. They also suggested that caecal pH measured via CE provides a useful measure of colonic fermentation, which might aid in the classification of patients with a broad spectrum of functional gastrointestinal disorders such as bloating and distension. Soluble biomarkers. Various soluble biomarkers can be found within the intestinal lumen, such as proteins, enzymes, microorganisms and their metabolic prod ucts 147 . Some attempts have been made to integrate sensors for the detection of these substances into CE devices. Up to now, these sensors have utilized either electrochemical 148, 149 or optical [150] [151] [152] methods. The single electrochemical sensing capsule 148, 149 incorporates a multi electrode sensor with onboard potentiostatic circuits to enable cyclic voltammetry and pulsed voltammetry of the gastrointestinal fluid sur rounding the capsule. To date, these capsules have been tested only in vitro using faecal water to demonstrate repeatable and reliable measurement. However, the shapes of voltammograms produced by the metal elec trodes of the electrochemical sensors were shown to change with time 148 . This result was partially attributed to the adsorption of organic matter onto the electrode surface, which would result in a reduced effective area for the electrochemical reactions used to sense the sur rounding gastrointestinal fluid. Mass transfer of the analyte to the sensor surface determines the response of electrochemical sensors. Hence, a change in surface area of the working electrode could potentially lead to erroneous measurement of the concentration of the con stituent soluble biomarkers of interest, raising questions about the long term stability of these devices.
The design of optical sensing capsules has been focused on detection of GIB using colorimetry 152 , spec troscopy 151 or fluoroscopy 83 . The colorimetric CE system developed by Qiao et al. 152 used a hue-saturation light colour detection method on blood cells selectively channelled into a measurement chamber. This cham ber included white LEDs for illumination, a colour sensor and an adsorptive colour sensitive film that undergoes a change from white to red in the presence of haemoglobin. In vitro trials with different blood concentrations showed that the system could measure haemoglobin concentrations as low as 2.375 mg per ml, which is less than that reported in areas of GIB 153 . The wireless spectroscopic Hemopill 151 (OVESCO, Tuebingen, Germany) has been tested in a preliminary human trial 154 . The battery powered capsule is 6.5 mm in diameter, 25.5 mm long and contains an optical sen sor to measure the optical absorption at 415 nm between an LED and a photodetector across a recessed channel. At this wavelength, optical transmission through blood is at a minimum and is three orders of magnitude less than transmission at a reference wavelength (720 nm). The optical sensor compares the change in absorp tion at 415 nm with the reference signal at 720 nm to detect haemoglobin. Initial tests were performed on a healthy volunteer with simulated GIB under a variety of conditions through periodic ingestion of 20 ml blood. These results were compared with baseline readings from the same volunteer under the same conditions without blood intake. The capsule successfully detected simulated GIB after each ingestion of blood, with the detection algorithm showing a correlation (R 2 = 0.9016) between changing sensor signal within 10 min of capsule ingestion and increased gastric blood concentration.
In 2018, Mimee et al. reported the development of a wireless capsule able to detect GIB in a porcine model using genetically engineered bacteria that lumi nesce in the presence of blood 155 . The Escherichia coli bacteria were also modified to enable the detection of thiosulfate and acyl homoserine lactone, which are potential biomarkers of gut inflammation and infectious bacteria, respectively 155 .
Gases and volatile organic compounds. The gut micro biome is a vast community of diverse microorganisms that is important for intestinal homeostasis and is linked to diseases such as IBD and CRC 147 . Direct intralumi nal characterization of the microbiome is not possible with current technology. Instead, the microbial popu lations of stool samples are a commonly used proxy of the gut microbiome in clinical research owing to the ease of collection. However, studies have shown differ ences between faecal and gut microbiomes 156 . Indirect measurement of the microbiome could be achieved by monitoring its metabolic by products 147 , as the com petition for resources between different microbial populations can lead to deviations in concentrations Potentiostatic circuits electronic circuits that enable the control of the voltage difference between electrodes in an electrochemical cell.
Cyclic voltammetry
a type of voltammetric experiment in which the potential is varied as a linear function of time. it is one of the most commonly used electrochemical techniques.
Pulsed voltammetry
a type of voltammetric experiment in which the varying potential consists of a series of increasing amplitude, with the potential returning to the initial value after each pulse.
Voltammograms
Plots of cell current versus the potential arising from a voltammetry experiment.
NATuRe RevIeWS | GASTRoENTERoLoGy & HEPAToLoGy of by products of microbial metabolism such as acetic acid, propionic acid and butyric acid, carbon dioxide, hydrogen, methane, ammonia, hydrogen sulfide and volatile fatty acids 157 . Kalantar Zadeh et al. developed a wireless CE device that was successfully used to provide real time meas urements of the level of gases such as hydrogen, carbon dioxide and oxygen along the gastrointestinal tract in five human volunteers 158 . The 9.8 mm diameter, 26 mm long capsules included a nonspecific, semiconducting metal oxide sensor responsive to all oxidizing gases under aerobic and anaerobic conditions. This sensor was calibrated to detect hydrogen, carbon dioxide and oxygen. Intestinal gas entered the capsule through a semi permeable membrane containing embedded nano particles that excluded water. The capsule was capable of operating for more than 4 days, and its excre tion could be detected using an onboard temperature sensor. Capsule localization was achieved by measur ing oxygen concentration levels throughout the gastro intestinal tract. This localization method successfully detected the gastric and small and large intestinal tran sit times for solid food. Recording the changing levels of hydrogen provided a means of understanding the microbial fermentation of food in the gut, the anaer obic process by which most small bowel and colonic microbiota residents obtain energy. However, attempts to correlate the changing levels of gas with diet types and faecal microbiomes of the volunteers were incon clusive. The accuracy of hydrogen and oxygen meas urements was better than 0.2%, whereas the accuracy of carbon dioxide measurements was 1%. This capsule was a refinement of a device that had been tested in animal models 159, 160 , but previous capsules did not have oxygen and temperature sensors, and the algorithm used to determine the gas levels was not as accurate in separating overlapping signals from the hydrogen and carbon dioxide sensors.
Trends for non-Wli capsules
The increasing variety of sensors and imaging technol ogies adapted for use in conventional endoscopy and CE is opening up new avenues of research. One area is virtual biopsy, which uses high resolution transmural imaging technologies to enable in situ, real time his tological examination without the need for a physical biopsy. Virtual biopsy is defined as the ability to make a histological examination by inspection of a site of interest in vivo using specific imaging modalities 161 . Although much of the work to date has utilized conven tional endoscopy because of the wider range of modal ities available and the absence of miniaturization and integration challenges caused by the space limitations of CE [162] [163] [164] [165] , some efforts have successfully demonstrated that virtual biopsy is possible in CE 4, 98, 99 . Another area of research opened up by the utilization of sensor technol ogy is computer aided diagnosis (CADx), which prom ises to automate the identification and interpretation of pathology 166, 167 . Although these two technologies have demonstrated promising results in laboratory and pre clinical studies, they are still in their infancy, and further work is required to assess the accuracy, sensitivity and specificity of these techniques in CE before they gain wider clinical acceptance.
A technical challenge unique to CE is localization. Currently, commercially available CE devices are pas sively moved through the gastrointestinal tract by peristaltic forces, and the clinician is unable to control the motion of the capsule or position it if an area of inter est is observed. The location of the capsule at these sites relative to some known frame of reference is required to enable further treatment or to follow up with additional observations. Localization of the capsule is the subject of much research in CE, and the following section gives a brief overview of the advantages and disadvantages of some of the methods used.
Virtual biopsy
Histological evaluation of tissue obtained from biopsy is a vital part of medical diagnosis. Biopsies can be per formed routinely during routine endoscopy through integrated intervention channels. However, capsules are hindered by limited payload capacity, unstable position ing and imprecise capsule and pathology localization. An alternative method to analyse tissue and achieve the same goal as histopathology that could be integrated into future CE devices is virtual biopsy. Theoretical advantages of this method include decreased risk of biopsy induced adverse events, faster diagnosis and the potential for reduced costs owing to the absence of further tissue processing and pathologic review 161, 168 . However, these advantages might be offset by the cost associated with increased surveillance frequency, missed detection of a malignant process 161 and techni cal challenges such as limited telemetry bandwidth of wireless CE.
Not all imaging modalities are suitable for virtual biopsy in CE. Suitable modalities must be able to acquire subsurface images of a resolution sufficient to view cellu lar structure within a time frame of tens of milliseconds to avoid motion artefacts owing to respiration or other causes 168 . This requirement precludes modalities such as WLI CE, chromoendoscopy, endomicroscopy and endocytoscopy, as they are limited by the maximum depth of light penetration of ~50 μm (ref.
169
). Currently, most research into virtual biopsy focuses primarily on OCT, confocal laser endomicroscopy and μUS. Of these, OCT and μUS have been utilized in CE 4, 98, 99 . Examples of images obtained with OCT and μUS are shown in fig. 2 .
OCT is an attractive imaging technology for this application, as it is capable of rapid volumetric imaging of mucosal and submucosal structures of the oesoph agus in microscopic detail (axial resolution ~10 µm and lateral resolution ~30 µm) and has been success fully demonstrated in ex vivo and in vivo trials 91, 98, 170, 171 . Various studies using OCT with conventional endos copy have demonstrated high resolution volumetric images comparable to those obtained from histology. Furthermore, an accuracy of 92.7% was reported for the detection of oesophageal carcinoma 172 , and a study of 33 patients with Barrett oesophagus demonstrated accu racy, sensitivity and specificity values of 78%, 68% and 82%, respectively, for the detection of dysplasia 173 . Initial www.nature.com/nrgastro demonstrations of OCT in CE have therefore shown its potential in differentiating between healthy and abnor mal tissue 98 . However, many of the current OCT CE devices require further integration and miniaturization to remove the tether to the external illumination source before this technology can be used to image the entire gastrointestinal tract.
Confocal laser endomicroscopy is slower than OCT because it can acquire only one image at a time as it scans through various focal depths and is therefore not suitable for CE 174 . Moreover, it has a small field of view, making it impractical to screen large areas of the bowel, requires exogenous fluorescent markers to ensure good sensitivity 91 and has not been currently miniaturized for use in CE. As previously noted, μUS can image mucosal and transmural pathology, which might enhance its use for virtual biopsy when combined with other diagnostic modalities 175 . This modality has been used in conven tional endoscopy through the use of fragile miniprobes that can be inserted into the biopsy channel. These mini probes can reach frequencies only as high as 30 MHz, but results of clinical trials have demonstrated the successful detection of Barrett oesophagus 176 , oesophageal cancer 177 and colorectal tumours 68 with accuracies of 88-98%, 84% and 88%, respectively. Initial development of μUS CE has shown good agreement between the ultrasonog raphy image and histology 4 , but further work is needed to verify whether μUS CE can achieve comparable or superior performance consistently.
Virtual biopsy has been proposed to replace histology in many settings 3, 178, 179 when endoscopic imaging tech nology matures and proficiency with these tools has increased. However, for this to be the case, high accu racy achievable with virtual biopsy methods must be established. In many of the studies published to date, the sensitivities and specificities of virtual biopsy techniques using conventional endoscopy are within 90.0% and 83.3%, respectively, for distinguishing Crohn's disease from ulcerative colitis using OCT 95 and within 80-90% for the detection of lesions 180 . In the latter case, whether such performance is acceptable owing to the risk of cancer development if lesions are missed is unclear. Additionally, as most of the research on virtual biopsy to date has been done with conventional endoscopy, further work will be needed to verify whether these results are transferable to CE owing to the mobile nature of the capsule and the effect of increased miniaturization and denser modality integration on system performance. Localization CE device localization is defined as knowledge of the position and orientation of the capsule with respect to either gastrointestinal tract anatomy and targets (internal localization) or external reference systems such as antennas (external localization). This infor mation is essential for accurate capsule navigation and to accurately and reliably map lesions and pathologies in the gastrointestinal tract with respect to internal or external frames of references for diagnosis, treatment and monitoring 181, 182 . Combining pathology detection and classification methodologies, such as the CADx methods discussed in the next section, with internal and external CE locali zation not only enables repeated monitoring of the same disease sites but also assists accurate and reliable active locomotion of CE devices, mainly in the case of mag netically driven, closed loop navigation in non rigid environments. The deformability of the gastrointestinal tract requires real time knowledge of the pose of the capsule with respect to the surrounding unstructured environment and vice versa. Thus, a hybrid approach, combining internal and external localization, together with autonomous or semi autonomous detection (depending on the accuracy, sensitivity and specificity of the detection method) and classification of pathologies, is required for the next generation of active locomotion capsules and smart endoscopes.
Autonomous or semi autonomous detection of pathologies using CE before their internal or exter nal localization is mainly performed using embed ded cameras with the support of advanced machine learning techniques 183, 184 . Embedding different sensing and imaging modalities into CE is very promising for both robotic control and diagnosis, as these methods enable virtual reconstruction of the internal structure of the gastrointestinal tract, potentially improving localization accuracy.
Internal localization of CE is performed mainly through optical imaging techniques, such as lumen reconstruction based methodologies using sparse or dense depth reconstruction techniques 185 , or through structured light 3D scanners 186 . It is used primarily to aid navigation of CE, perform direct intervention on diseases and retarget pathological sites for subsequent treatment or follow up. Internal localization is often combined with external localization for computer aided NATuRe RevIeWS | GASTRoENTERoLoGy & HEPAToLoGy active capsule locomotion within laboratory proto types 185, 187 . A detailed discussion of CE locomotion is available elsewhere 185 . Current external localization methods such as radio frequency triangulation are integrated in the PillCam systems. Radio frequency localization algorithms are based on triangulation of the telemetry signals emit ted by the CE device by external antennas (usually eight) located around the abdomen. This method was experimentally determined to have an average and maximum positional error of 37.7 mm and 114 mm, respectively 188, 189 . Accuracy is low but can be considered adequate for current wireless passive CE devices, as they do not require additional modules to be integrated and they do not require accurate pose information owing to the lack of active motion control.
Several academic teams have focused their research on other external localization techniques based on mag netic field sources that look to be a promising solution for active locomotion of CE devices as a compromise between integration of components in a small space, computational complexity and overall accuracy. The main advantage of these approaches over other local ization methodologies is that low frequency magnetic signals can pass through human tissue without attenu ation, which can be an advantage over radio frequency approaches depending on the frequency 190 ; additionally, magnetic sensors do not need line ofsight vision to detect the capsule. Finally, the position and orientation accuracies of a magnetic based localization approach are usually superior to those of radio frequency localization methods. For example, a study by Taddese et al. 191 using magnetic based localization was able to achieve posi tion and orientation accuracies lower than 5 mm and 6°, respectively. Magnetic localization methods are expected to take the lead over radio frequency approaches when they mature and new design solutions for capsules with the required integrated sensors are achieved. Supple mentary Table 2 summarizes studies on magnetic based capsule localization.
Computer-aided diagnosis
Currently, CE devices can produce up to six frames per second (PillCam SB3, Given Imaging), generat ing thousands of images during passage through the gastrointestinal tract. Screening of the images can take 0.5-1.0 hours for a single human reader using high speed reading techniques 192 and lead to 6-20% of pathology occurrences being missed [192] [193] [194] [195] . This issue will be exacerbated by both an increase in the number of modalities provided by a capsule and increased CE usage owing to reduced costs. 
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Initial approaches to automate aspects of capsule data interpretation using colour image analysis to create a sus pected blood indicator have been developed. However, reception by the clinical community has been mixed [196] [197] [198] owing to its limited sensitivity and specificity, which one study 199 has characterized as 56.4% and 33.5%, respectively. CADx can be defined as the use of computer algo rithms to process and interpret medical data for the purposes of identifying pathology. This approach is rela tively new in gastroenterology, but similar techniques are widely used in radiology, with several systems already approved by the FDA 200 . Algorithms to automate the detection of lesions [201] [202] [203] , ulcers [204] [205] [206] , tumours [207] [208] [209] [210] [211] and polyps 212 from images and video taken with commercial WLI CE devices in the gastrointestinal tract have been reported, with bleeding [196] [197] [198] [213] [214] [215] [216] receiving most atten tion, as it is often an indication for many gastrointesti nal disorders, such as CRC and Crohn's disease 217 . Some studies have begun to address the identification of more than a single abnormality, with methods reported for simultaneous detection of small bowel ulcers and polyps 218 and of gastrointestinal bleeding and ulcers 219 . This task is not trivial, as demonstrated in the study by Gan 203 , which illustrated the varying accuracy of an algorithm based on the separation and identification of suspected enteric lesions by their associated colours in correctly identifying different types of enteric lesions because of the complexity and diverse multiformity. Comparing the effectiveness of these proposed methods of CADx with each other in detail is difficult owing to the lack of stand ardized data sets of CE images. The reported accuracy, sensitivity and specificity values of some of the studies found in the literature are shown in Table 4 , although accurate comparison of these algorithms is limited due to the lack of standardised data sets.
To date, no studies have been performed on the use of CADx in conjunction with capsule modalities other than WLI because of the limited number of non WLI CE devices available. However, initial studies on the use of CADx with non capsulebased endoscopy have been conducted using modalities such as OCT [220] [221] [222] , autofluorescence 223 and NBI [224] [225] [226] [227] 220 . Subsequent in vivo studies by Ughi et al. used a tethered capsule like device to identify Barrett oesophagus in human volun teers. Results showed sensitivity, specificity and accuracy values of 94%, 93% and 94%, respectively. However, the study population was limited, with one healthy con trol and two with oesophageal abnormalities 221 . These studies demonstrate that CADx has the potential to be used with specific non WLI modalities to detect various gastrointestinal pathologies.
Conclusions
Looking ahead, several issues need to be addressed to translate this nascent research in non WLI CE into wider clinical practice (box 1). Many CE devices are being developed with various imaging and sensing modalities to overcome the limitations of WLI, but these are still in early stages of development, with many yet to undergo in vivo animal and human trials. Furthermore, the clini cal efficacy of the devices that have been used in humans still needs to be verified, as the studies conducted to date are typically limited by small sample sizes. Large clini cal trials are required to ascertain the diagnostic yield of these non WLI capsules for various pathologies.
The specialization of CE, already seen to some extent with WLI CE devices modified to perform bet ter in different parts of the gastrointestinal tract, will probably continue. By combining multiple modalities within a single device, the diagnostic potential will be increased beyond what can be achieved with single modality devices. A multimodal approach will facili tate both CADx, as already observed with conventional endoscopy, and virtual biopsy by improving accuracy, sensitivity and specificity. However, the combination of modalities for the diagnosis of specific gastrointes tinal diseases still needs to be determined. Other tech nical challenges include improved localization, which is crucial for virtual biopsy to enable accurate, regular monitoring of pathology.
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Box 1 | Future challenges
• White light imaging (WlI) capsule endoscopy (Ce) is limited to surface visualization and has limited specificity for diagnosis owing to similarities in the mucosal appearance of different small bowel diseases.
• Research and development of non-WlI capsules have increased in recent years.
• Some of these non-WlI capsules are now commercially available, such as the SmartPill.
• most of the non-WlI capsules are still at the prototype stage, and the diagnostic efficacy of their sensing and imaging modalities, as well as their cost-benefit ratio, needs to be validated through extensive clinical trials.
• Non-WlI capsules capable of measuring pH, pressure changes, concentration of chemicals and much more have been developed.
• one challenge of WlI and non-WlI Ce is the need for accurate means of determining the position of the capsule at all times to enable the localization of pathologies for subsequent follow-up.
• Non-WlI capsules such as those capable of optical coherence tomography or microultrasonography have the potential to provide Ce with the capability of providing real-time, in vivo, high-resolution transmural imaging that could remove the need for tissue biopsy.
• one challenge for clinicians in the future will be the increasing amount of data that will need to be reviewed for diagnosis owing to the increased use of WlI and non-WlI Ce.
• This challenge has spurred research into computer-aided diagnosis (CADx), whereby algorithms are used to automate the identification and interpretation of pathologies.
• The lack of standardized data sets has impeded the accurate comparison of various CADx algorithms.
• CADx could require the use of multiple modalities in non-WlI Ce to improve accuracy and specificity, which will require challenges related to miniaturization, integration and power consumption of Ce systems to be overcome.
